Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.
School of Medicine, Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.
Cardiovasc Res. 2022 May 6;118(6):1452-1465. doi: 10.1093/cvr/cvab174.
Cardiovascular diseases are characterized by chronic vascular dysfunction and provoke pathological remodelling events, such as neointima formation, atherosclerotic lesion development, and adventitial fibrosis. While lineage-tracing studies have shown that phenotypically modulated smooth muscle cells (SMCs) are the major cellular component of neointimal lesions, the cellular origins and microenvironmental signalling mechanisms that underlie remodelling along the adventitial vascular layer are not fully understood. However, a growing body of evidence supports a unique population of adventitial lineage-restricted progenitor cells expressing the stem cell marker, stem cell antigen-1 (Sca1; AdvSca1 cells) as important effectors of adventitial remodelling and suggests that they are at least partially responsible for subsequent pathological changes that occur in the media and intima. AdvSca1 cells are being studied in murine models of atherosclerosis, perivascular fibrosis, and neointima formation in response to acute vascular injury. Depending on the experimental conditions, AdvSca1 cells exhibit the capacity to differentiate into SMCs, endothelial cells, chondrocytes, adipocytes, and pro-remodelling cells, such as myofibroblasts and macrophages. These data indicate that AdvSca1 cells may be a targetable cell population to influence the outcomes of pathologic vascular remodelling. Important questions remain regarding the origins of AdvSca1 cells and the essential signalling mechanisms and microenvironmental factors that regulate both maintenance of their stem-like, progenitor phenotype and their differentiation into lineage-specified cell types. Adding complexity to the story, recent data indicate that the collective population of adventitial progenitor cells is likely composed of several smaller, lineage-restricted subpopulations, which are not fully defined by their transcriptomic profile and differentiation capabilities. The aim of this review is to outline the heterogeneity of Sca1+ adventitial progenitor cells, summarize their role in vascular homeostasis and remodelling, and comment on their translational relevance in humans.
心血管疾病的特征是慢性血管功能障碍,并引发病理性重塑事件,如新生内膜形成、动脉粥样硬化病变发展和外膜纤维化。虽然谱系追踪研究表明,表型调节的平滑肌细胞(SMC)是新生内膜病变的主要细胞成分,但尚不完全清楚重塑沿外膜血管层的细胞起源和微环境信号机制。然而,越来越多的证据支持表达干细胞标志物干细胞抗原-1(Sca1;AdvSca1 细胞)的独特外膜谱系限制祖细胞群体作为外膜重塑的重要效应物,并表明它们至少部分负责随后发生在中膜和内膜的病理性变化。AdvSca1 细胞正在动脉粥样硬化、血管周围纤维化和急性血管损伤后新生内膜形成的小鼠模型中进行研究。根据实验条件的不同,AdvSca1 细胞具有分化为 SMC、内皮细胞、软骨细胞、脂肪细胞和促重塑细胞(如肌成纤维细胞和巨噬细胞)的能力。这些数据表明,AdvSca1 细胞可能是一个可靶向的细胞群体,以影响病理性血管重塑的结果。关于 AdvSca1 细胞的起源以及调节其维持干细胞样祖细胞表型和分化为谱系特异性细胞类型的关键信号机制和微环境因素,仍有一些重要问题亟待解决。使情况更加复杂的是,最近的数据表明,外膜祖细胞的总体群可能由几个较小的、谱系限制的亚群组成,这些亚群不能完全根据其转录组谱和分化能力来定义。本综述的目的是概述 Sca1+外膜祖细胞的异质性,总结它们在血管稳态和重塑中的作用,并评论它们在人类中的转化相关性。